Erik W. Holy

2.8k total citations
46 papers, 1.4k citations indexed

About

Erik W. Holy is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Immunology. According to data from OpenAlex, Erik W. Holy has authored 46 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 12 papers in Epidemiology and 11 papers in Immunology. Recurrent topics in Erik W. Holy's work include Cardiac Valve Diseases and Treatments (14 papers), Infective Endocarditis Diagnosis and Management (10 papers) and Cardiac Imaging and Diagnostics (9 papers). Erik W. Holy is often cited by papers focused on Cardiac Valve Diseases and Treatments (14 papers), Infective Endocarditis Diagnosis and Management (10 papers) and Cardiac Imaging and Diagnostics (9 papers). Erik W. Holy collaborates with scholars based in Switzerland, Germany and United Kingdom. Erik W. Holy's co-authors include Thomas F. Lüscher, Felix C. Tanner, Giovanni G. Camici, Alexander Akhmedov, Jürg H. Beer, Gert Richardt, Mohamed Abdel‐Wahab, Abdelhakim Allali, Mohamed El‐Mawardy and Julia Kebernik and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Erik W. Holy

45 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik W. Holy Switzerland 21 809 517 238 200 176 46 1.4k
Amin Polzin Germany 22 872 1.1× 372 0.7× 172 0.7× 396 2.0× 242 1.4× 138 1.5k
Gaetano Tanzilli Italy 24 1.1k 1.3× 223 0.4× 225 0.9× 407 2.0× 198 1.1× 108 1.7k
Tae Hoon Ahn South Korea 18 702 0.9× 237 0.5× 114 0.5× 502 2.5× 87 0.5× 90 1.2k
Hideaki Jinnouchi Japan 15 722 0.9× 130 0.3× 114 0.5× 372 1.9× 273 1.6× 40 1.3k
Enrico Mangieri Italy 20 898 1.1× 202 0.4× 356 1.5× 327 1.6× 132 0.8× 69 1.5k
Francesco Scopacasa Italy 19 436 0.5× 340 0.7× 200 0.8× 451 2.3× 239 1.4× 29 1.3k
Burak Pamukçu Türkiye 21 682 0.8× 170 0.3× 127 0.5× 213 1.1× 230 1.3× 45 1.4k
D.P. Mikhailidis United Kingdom 19 621 0.8× 304 0.6× 615 2.6× 495 2.5× 115 0.7× 52 1.5k
Toshihiko Uchida Japan 17 464 0.6× 455 0.9× 183 0.8× 397 2.0× 223 1.3× 43 1.3k
Giuseppe Giugliano Italy 20 658 0.8× 342 0.7× 477 2.0× 605 3.0× 423 2.4× 79 1.8k

Countries citing papers authored by Erik W. Holy

Since Specialization
Citations

This map shows the geographic impact of Erik W. Holy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik W. Holy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik W. Holy more than expected).

Fields of papers citing papers by Erik W. Holy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik W. Holy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik W. Holy. The network helps show where Erik W. Holy may publish in the future.

Co-authorship network of co-authors of Erik W. Holy

This figure shows the co-authorship network connecting the top 25 collaborators of Erik W. Holy. A scholar is included among the top collaborators of Erik W. Holy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik W. Holy. Erik W. Holy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Holy, Erik W., et al.. (2023). Clinical outcomes of ultrasound-assisted coagulation monitoring-adjusted catheter-directed thrombolysis for acute pulmonary embolism. Thrombosis Research. 225. 73–78. 2 indexed citations
3.
Puspitasari, Yustina M., Stefano Ministrini, Luca Liberale, et al.. (2023). Antibody-mediated PCSK9 neutralization worsens outcome after bare-metal stent implantation in mice. Vascular Pharmacology. 153. 107170–107170. 1 indexed citations
5.
Jakob, Philipp, Erik W. Holy, Patrick T. Siegrist, et al.. (2021). Perkutane koronare Revaskularisation beim chronischen Koronarsyndrom: wann sinnvoll, wann nicht?. Praxis. 110(6). 313–323. 1 indexed citations
6.
Holy, Erik W., Philipp Jakob, Robert Manka, et al.. (2020). Impact of a nationwide COVID-19 lockdown on acute coronary syndrome referrals. Cardiology Journal. 27(5). 633–635. 3 indexed citations
7.
Liberale, Luca, Erik W. Holy, Alexander Akhmedov, et al.. (2019). Interleukin-1β Mediates Arterial Thrombus Formation via NET-Associated Tissue Factor. Journal of Clinical Medicine. 8(12). 2072–2072. 69 indexed citations
8.
D’Ascenzo, Fabrizio, Stefano Salizzoni, Andrea Saglietto, et al.. (2019). Incidence, predictors and cerebrovascular consequences of leaflet thrombosis after transcatheter aortic valve implantation: a systematic review and meta-analysis. European Journal of Cardio-Thoracic Surgery. 56(3). 488–494. 44 indexed citations
9.
Abdel‐Wahab, Mohamed, Mohammad Abdelghani, Yosuke Miyazaki, et al.. (2018). A Novel Angiographic Quantification of Aortic Regurgitation After TAVR Provides an Accurate Estimation of Regurgitation Fraction Derived From Cardiac Magnetic Resonance Imaging. JACC: Cardiovascular Interventions. 11(3). 287–297. 25 indexed citations
10.
Jose, John, Dmitriy S. Sulimov, Mohamed El‐Mawardy, et al.. (2017). Clinical Bioprosthetic Heart Valve Thrombosis After Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 10(7). 686–697. 162 indexed citations
11.
Stähli, Barbara E., Erik W. Holy, Thi Dan Linh Nguyen‐Kim, et al.. (2017). Impact of stroke volume assessment by integrating multi-detector computed tomography and Doppler data on the classification of aortic stenosis. International Journal of Cardiology. 246. 80–86. 11 indexed citations
12.
Schmidt, Tobias, Christian Frerker, Hannes Alessandrini, et al.. (2016). Redo TAVI: initial experience at two German centres. EuroIntervention. 12(7). 875–882. 21 indexed citations
13.
Toggweiler, Stefan, Stefan Stortecky, Erik W. Holy, et al.. (2016). The Electrocardiogram After Transcatheter Aortic Valve Replacement Determines the Risk for Post-Procedural High-Degree AV Block and the Need for Telemetry Monitoring. JACC: Cardiovascular Interventions. 9(12). 1269–1276. 98 indexed citations
14.
Possner, Mathias, Jan Vontobel, Thi Dan Linh Nguyen‐Kim, et al.. (2016). Prognostic value of aortic regurgitation after TAVI in patients with chronic kidney disease. International Journal of Cardiology. 221. 180–187. 6 indexed citations
15.
Speer, Thimoteus, Erik W. Holy, Stephen Zewinger, et al.. (2014). Carbamylated low-density lipoprotein induces endothelial dysfunction. European Heart Journal. 35(43). 3021–3032. 110 indexed citations
16.
Holy, Erik W., Philipp Jakob, Thomas Eickner, et al.. (2013). PI3K/p110  inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design. European Heart Journal. 35(12). 808–820. 32 indexed citations
17.
Akhmedov, Alexander, Simona Stivala, Erik W. Holy, et al.. (2012). Abstract 15247: Endothelial Overexpression of LOX-1 Protects from in vivo Arterial Thrombosis and Modulates TF Expression. Circulation. 126. 1 indexed citations
18.
Holy, Erik W., Marc Forestier, E Richter, et al.. (2011). Dietary α-Linolenic Acid Inhibits Arterial Thrombus Formation, Tissue Factor Expression, and Platelet Activation. Arteriosclerosis Thrombosis and Vascular Biology. 31(8). 1772–1780. 74 indexed citations
19.
Breitenstein, Alexander, Sokrates Stein, Erik W. Holy, et al.. (2010). Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells. Cardiovascular Research. 89(2). 464–472. 87 indexed citations
20.
Schmid, Werner, et al.. (2006). Redox-sensitive impairment of porcine coronary artery vasodilation by hypochlorite-modified LDL. Atherosclerosis. 190(2). 330–337. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026